Study S002186

Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02344641
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: UNKNOWN
Enrollment: 234
Start: 2015-01
Primary completion: 2016-12
Lead sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions: Type 2 Diabetes Mellitus; Heart Failure
Interventions: DRUG:Exenatide
Results posted: FALSE

Registered primary outcomes

The change in plasma NT-proBNP level after using exenatide for 4 weeks [4 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.